Cargando…
Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
OBJECTIVE: To investigate the effects of fatigue on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib. PATIENTS AND METHODS: A retrospective analysis of 182 cases of patients with advanced hepatocellular carcinoma treated with sorafenib in our hospital from Octob...
Autores principales: | Qiu, Xuan, Li, Manjiang, Wu, Liqun, Xin, Yang, Mu, Siyu, Li, Tianxiang, Song, Kangjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481349/ https://www.ncbi.nlm.nih.gov/pubmed/32943932 http://dx.doi.org/10.2147/CMAR.S233448 |
Ejemplares similares
-
Two important factors affecting the prognosis of patients treated
with sorafenib followed by regorafenib for advanced hepatocellular
carcinoma
por: Li, Ning, et al.
Publicado: (2022) -
The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE
por: Kimura, Yusuke, et al.
Publicado: (2020) -
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Imai, Kenji, et al.
Publicado: (2015) -
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
por: Caputo, Francesco, et al.
Publicado: (2020) -
Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)